Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Dianemycin | C47H78O14 | 35865-33-9 | Details |
| NAN-190 hydrobromide | C23H28BrN3O3 | 115338-32-4 | Details |
| Nav1.7-IN-6 | C25H25ClF6N2O4S | 1788066-71-6 | Details |
| Nav1.1 activator 1 | C24H23F3N4O | 2332897-85-3 | Details |
| Nateglinide D5；Senaglinide D5;A4166 D5 | C19H22D5NO3 | 1227666-13-8 | Details |
| Natalizumab | C40H55N7O11S | 189261-10-7 | Details |
| Naratriptan D3 Hydrochloride；GR-85548A D3 | C17H25ClN3O2S | 1190021-64-7 | Details |
| Naquotinib mesylate；ASP8273 (mesylate) | C31H46N8O6S | 1448237-05-5 | Details |
| Cefoperazone sodium salt | C25H28N9NaO8S2 | 62893-20-3 | Details |
| Naphthoquine phosphate | C24H31ClN3O5P | 173531-58-3 | Details |
| Nav1.7-IN-3 | C17H20ClFN4O2S2 | 1788872-06-9 | Details |
| Nav1.7 inhibitor | C15H11Cl3FNO4S | 1355631-24-1 | Details |
| Nav1.7-IN-2 | C22H22FN5O2 | 1332295-35-8 | Details |
| NCGC00247743 | C24H29N3O2 | 1435192-04-3 | Details |
| NCGC00249987 | C16H11FN4O2S | 1384864-80-5 | Details |
| NCT-506 | C25H23FN4O3S | 2231098-99-8 | Details |
| NCI172112；NSC268497;NSC172112 | C14H23Cl2N3O2 | 56605-16-4 | Details |
| Trans (2,3)-Dihydrotetrabenazine；(2R,3R,11bR)-rel-Dihydrotetrabenazine;(2R,3R,11bR)-rel-DHTBZ | C19H29NO3 | 171598-74-6 | Details |
| NBTGR | C17H18N6O6S | 13153-27-0 | Details |
| Naveglitazar racemate | C25H26O6 | 916085-47-7 | Details |
| Naspm；1-Naphthylacetyl spermine | C22H34N4O | 122306-11-0 | Details |
| NBDHEX | C12H15N3O4S | 787634-60-0 | Details |
| Naspm trihydrochloride | C22H35ClN4O | 1049731-36-3 | Details |
| Navitoclax-piperazine | C47H56ClF3N6O5S3 | 2143096-93-7 | Details |
| NaV1.7 inhibitor-1 | C23H30FNO4S | 1494585-79-3 | Details |
| NCT-505 | C27H28FN5O3S | 2231079-74-4 | Details |
| Sisomicin Sulfate | C19H39N5O11S | 53179-09-2 | Details |
| NCGC00229600 | C30H29N3O3 | 1338824-20-6 | Details |
| NB-598 Maleate | C31H35NO5S2 | 155294-62-5 | Details |
| NCX899 | C23H33N3O8 | 690655-41-5 | Details |
| NB-598 hydrochloride | C27H32ClNOS2 | 136719-25-0 | Details |
| Ethidium bromide；EtBr;Homidium bromide;EB | C21H20BrN3 | 1239-45-8 | Details |
| Necrostatin 2 | C13H12ClN3O2 | 852391-19-6 | Details |
| Necrostatin 2 S enantiomer | C13H12ClN3O2 | 852391-20-9 | Details |
| Nec-4 | C15H13ClFN3O | 1041644-43-2 | Details |
| NED-3238 | C17H28BN3O4 | 2389062-09-1 | Details |
| Nepafenac-d5；AHR-9434 D5;Nepafenac D5;AL-6515 D5 | C15H14N2O2 | 1246814-53-8 | Details |
| Nebracetam hydrochloride | C12H17ClN2O | 1177279-49-0 | Details |
| Ned 19 | C30H31FN4O3 | 874374-25-1 | Details |
| NEO 376 | C20H24ClN3O | 496921-73-4 | Details |
| Netupitant metabolite Monohydroxy Netupitant；Monohydroxy Netupitant | C30H32F6N4O2 | 910808-12-7 | Details |
| Netupitant metabolite N-desmethyl Netupitant；N-desmethyl Netupitant | C29H30F6N4O | 290296-72-9 | Details |
| Neurotoxin Inhibitor | C19H14N4OS | 951571-70-3 | Details |
| Netupitant metabolite Netupitant N-oxide；Netupitant N-oxide | C30H32F6N4O2 | 910808-11-6 | Details |
| Nexopamil racemate | C24H40N2O3 | 116759-35-4 | Details |
| Acetylcholine chloride | C7H16ClNO2 | 60-31-1 | Details |
| NecroX-5 | C26H35N3O6S2 | 1383718-29-3 | Details |
| NF-56-EJ40 | C27H29N3O3 | 2380230-73-7 | Details |
| NS-3-008 hydrochloride | C14H24ClN3 | 1172854-54-4 | Details |
| NSC117079 | C20H15N3O7S2 | 500363-63-3 | Details |
| NPS ALX Compound 4a | C25H25N3O2S | 299433-10-6 | Details |
| NPS ALX Compound 4a dihydrochloride | C25H26ClN3O2S | 1781934-44-8 | Details |
| NSC 601980 (analog) | C15H14N4 | 91757-46-9 | Details |
| NRA-0160 | C24H23F2N3OS | 204718-47-8 | Details |
| NR1H4 activator 1 | C34H53NO7S | 2242855-68-9 | Details |
| NS8593 hydrochloride | C17H17N3.ClH | 875755-24-1 | Details |
| Nrf2-IN-1 | C21H22ClN3O2 | 1610022-76-8 | Details |
| NS19504 | C10H9BrN2S | 327062-46-4 | Details |
| Nourseothricin sulfate | C44H82N18O21S | 96736-11-7 | Details |
| NPB | C29H31Cl2N3O2 | 2247491-97-8 | Details |
| NSC232003 | C6H7N3O3 | 1905453-18-0 | Details |
| CB-103 | C15H18N2O | 218457-67-1 | Details |
| Bacitracin | C66H102N17O16S | 1405-87-4 | Details |
| Niraparib metabolite M1；Niraparib carboxylic acid metabolite M1;M1 metabolite of niraparib | C19H19N3O2 | 1476777-06-6 | Details |
| Nitazoxanide-d4；NSC-697855 D4;Nitazoxanide D4;NTZ D4 | C12H9N3O5S | 1246819-17-9 | Details |
| NK-1 Antagonist 1；Rolapitant intermediate | C25H23F6N5O2 | 873947-10-5 | Details |
| Norvancomycin hydrochloride；Desmethyl-vancomycin hydrochloride | C65H74Cl3N9O24 | 213997-73-0 | Details |
| Norverapamil；(±)-Norverapamil;D591 | C26H36N2O4 | 67018-85-3 | Details |
| nor-NOHA acetate；Nω-Hydroxy-nor-L-arginine acetate | C5H12N4O3 ? 2C2H4O2 | 1140844-63-8 | Details |
| NNC45-0781 | C27H29NO3 | 207277-66-5 | Details |
| Ceftriaxone sodium hydrate | C18H21N8NaO8S3 | 104376-79-6 | Details |
| Nitroxazepine | C18H19N3O4 | 47439-36-1 | Details |
| NNC 55-0396 | C30H39ClFN3O2 | 357400-13-6 | Details |
| NMDA-IN-1 | C20H23ClFN3O | 700878-19-9 | Details |
| NHE3-IN-1 | C12H10ClN3S | 632355-68-1 | Details |
| Nicardipine-d3 hydrochloride；Nicardipine D3 hydrochloride;YC-93 D3 | C26H26D3N3O6 | 1432061-50-1 | Details |
| Nilotinib-d6；AMN107 D6;Nilotinib D6 | C28H16D6F3N7O | 1268356-17-7 | Details |
| Nevanimibe；ATR-101;PD-132301 | C27H39N3O | 133825-80-6 | Details |
| NIM811；SDZ NIM811;(Melle-4)cyclosporin | C62H111N11O12 | 143205-42-9 | Details |
| Nimesulide D5 | C13H7D5N2O5S | 1330180-22-7 | Details |
| Nifedipine-d6；Nifedipine D6;BAY-a-1040 D6 | C17H12D6N2O6 | 1188266-14-9 | Details |
| Niperotidine | C20H26N4O5S | 84845-75-0 | Details |
| Trifluoperazine dihydrochloride | C21H26Cl2F3N3S | 440-17-5 | Details |
| Cefuroxime sodium | C16H15N4O8S.Na | 56238-63-2 | Details |
| Norbinaltorphimine dihydrochloride | C40H44ClN3O6 | 113158-34-2 | Details |
| NMDI14 | C21H25N3O4S | 307519-88-6 | Details |
| NMS-859 | C15H12ClN3O3S | 1449236-96-7 | Details |
| NMS-P715 | C35H39F3N8O3 | 1202055-32-0 | Details |
| NITD-349 | C17H20F2N2O | 1473450-62-2 | Details |
| Nifursemizone | C8H10N4O4 | 5579-89-5 | Details |
| NIC3 | C26H36N2O4 | 494830-67-0 | Details |
| NF546 | C47H44N6Na4O17P4 | 1006028-37-0 | Details |
| NFAT Transcription Factor Regulator-1 | C17H10F6N4O2 | 245747-71-1 | Details |
| NB-360 | C21H19F4N5O2 | 1262857-73-7 | Details |
| Nevanimibe hydrochloride | C27H40ClN3O | 133825-81-7 | Details |
| Nosantine racemate；NPT-15392 racemate | C14H22N4O2 | 75166-67-5 | Details |
| Norverapamil-d7；D591 D7;(±)-Norverapamil D7;Norverapamil D7 | C26H29D7N2O4 | 263175-44-6 | Details |
| NOT Receptor Modulator 1；2-(3-(2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl)phenyl)propan-2-ol | C22H19ClN2O | 1015231-98-7 | Details |
| NSC 146109 hydrochloride | C17H17ClN2S | 59474-01-0 | Details |
| Netropsin dihydrochloride | C18H27ClN10O3 | 18133-22-7 | Details |
| Product Total： Product Page： | ||||
| 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 | ||||